Cargando…
A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine
Clozapine remains the drug of choice for resistant schizophrenia. However, its dose-response relationship is still controversial. The current investigation aimed to develop a repeated time-to-positive symptoms improvement following the onset of clozapine treatment in Malaysian schizophrenia spectrum...
Autores principales: | Albitar, Orwa, Harun, Sabariah Noor, Ahmad, Siti Nor Aizah, Sheikh Ghadzi, Siti Maisharah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401956/ https://www.ncbi.nlm.nih.gov/pubmed/34452082 http://dx.doi.org/10.3390/pharmaceutics13081121 |
Ejemplares similares
-
Population Pharmacokinetics of Clozapine: A Systematic Review
por: Albitar, Orwa, et al.
Publicado: (2020) -
Risk factors for mortality among COVID-19 patients
por: Albitar, Orwa, et al.
Publicado: (2020) -
Predictive model of recurrent ischemic stroke: model development from real-world data
por: Elhefnawy, Marwa Elsaeed, et al.
Publicado: (2023) -
Pharmacometrics Approaches and its Applications in Diabetes: An Overview
por: Aziz, Sohail, et al.
Publicado: (2021) -
Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?
por: Aziz, Sohail, et al.
Publicado: (2021)